Sequana Medical NV
Research Sequana Medical NV (SEQUA) on Bullrun: market cap EUR 47.76M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSEQUA
- ExchangeBR
- CountryBelgium
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 47.76M
- Financial periodFY2024
- RevenueEUR 105.50K
- Revenue growth-85.2%
- Net income-EUR 44.65M
- Free cash flow-EUR 20.35M
- Gross margin74.9%
Valuation Snapshot
latest market cap is EUR 47.76M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | EUR 105.50K | -EUR 44.65M | -EUR 20.35M | 74.9% | -1.22 | EUR 3.81M | EUR 40.11M | -EUR 44.38M |
| FY2023 | EUR 712.17K | -EUR 32.56M | -EUR 29.77M | 77.0% | -1.22 | EUR 2.58M | EUR 17.52M | -EUR 19.47M |
| FY2022 | EUR 922.69K | -EUR 30.76M | -EUR 28.16M | 77.8% | -1.35 | EUR 18.87M | EUR 17.59M | -EUR 2.15M |
| FY2021 | EUR 370.50K | -EUR 23.62M | -EUR 23.94M | 79.3% | -1.3 | EUR 9.60M | EUR 8.09M | -EUR 786.92K |
| FY2020 | EUR 963.28K | -EUR 19.11M | -EUR 17.14M | 79.0% | n/a | EUR 11.02M | EUR 7.47M | EUR 112.76K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-29 | EUR 47.76M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Sequana Medical NV
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offers alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body. Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sequana Medical NV's market cap?
Sequana Medical NV's market capitalization is EUR 47.76M.
What does Sequana Medical NV do?
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offers alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body. Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.